Detalhe da pesquisa
1.
Postchallenge administration of brincidofovir protects healthy and immune-deficient mice reconstituted with limited numbers of T cells from lethal challenge with IHD-J-Luc vaccinia virus.
J Virol
; 89(6): 3295-307, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25589648
2.
Pharmacokinetics and Efficacy of a Potential Smallpox Therapeutic, Brincidofovir, in a Lethal Monkeypox Virus Animal Model.
mSphere
; 6(1)2021 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33536322
3.
Efficacy of delayed brincidofovir treatment against a lethal rabbitpox virus challenge in New Zealand White rabbits.
Antiviral Res
; 143: 278-286, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28392420
4.
LC-MS/MS assay and dog pharmacokinetics of the dimeric pyrrolobenzodiazepine SJG-136 (NSC 694501).
J Chromatogr B Analyt Technol Biomed Life Sci
; 840(1): 56-62, 2006 Aug 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-16730244
5.
Correction for Hutson et al., "Pharmacokinetics and Efficacy of a Potential Smallpox Therapeutic, Brincidofovir, in a Lethal Monkeypox Virus Animal Model".
mSphere
; 6(1)2021 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33597175
6.
Liquid chromatography-electrospray tandem mass spectrometric assay suitable for quantitation of halofuginone in plasma.
J Chromatogr B Analyt Technol Biomed Life Sci
; 810(1): 35-40, 2004 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15358305